SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Tabula Rasa HealthCare, Inc. (TRHC) .
Criteria proven by this page:
- VALUE (10/100, Fail) — analyst consensus target implies downside from the current price ($3.00, 71.4%).
- Analyst consensus target $3.00 (-71.4% downside) — analysts see meaningful downside risk at the current price level.
Overall SharesGrow Score: 23/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
✗
VALUE
10/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — TRHC
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.85
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-3.18
Book Value / Share$0.00
Revenue / Share$12.33
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
Analyst Target$3.00 (-71.4%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2013 |
$-0.39 |
$25.14M |
$-3.87M |
-15.4% |
| 2014 |
$-0.11 |
$48.43M |
$-1.11M |
-2.3% |
| 2015 |
$-0.29 |
$70.04M |
$-2.86M |
-4.1% |
| 2016 |
$-0.54 |
$94.06M |
$-6.25M |
-6.6% |
| 2017 |
$0.68 |
$134.55M |
$14.3M |
10.6% |
| 2018 |
$-2.48 |
$204.27M |
$-47.27M |
-23.1% |
| 2019 |
$-1.57 |
$284.71M |
$-32.44M |
-11.4% |
| 2020 |
$-3.71 |
$297.22M |
$-80.97M |
-27.2% |
| 2021 |
$-3.39 |
$331.26M |
$-79.06M |
-23.9% |
| 2022 |
$-3.18 |
$299.52M |
$-77.33M |
-25.8% |
